tbuckley/cabot-search huggingface dataset:
A First-in-Human Phase 1 Trial of NX-1607, a First-in-Class Oral CBL-B Inhibitor, in Patients with Advanced Malignancies Including DLBCL
Authors: Graham P. Collins, William Townsend, Ahmed Abdulgawad, Swathi Namburi, Anja Williams, Ana Filipa Palma DosReis, Matthew G. Krebs, Jeff Evans, Sarah P. Blagden, Ruth Plummer, Daniel Hochhauser, Adam Sharp, George Cole, Seema Rogers, Daniel Chan, Sarah Whelan, Dima El-Sharkawi
Journal: Blood (2023)
Sry-Box Transcription Factor 9 (SOX9)-Driven Mesenchymal Stromal Cell Differentiation Signature As a Determinant of Induction Chemotherapy Responsiveness in Acute Myeloid Leukemia Core Bone Marrow Biopsies
Authors: Seo-Ho Lee, Dennis M Bonal, Diana Olguta Treaba, Anna Dorota Chorzalska, Makayla Pardo, John L. Reagan, Adam J Olszewski, Patrycja M. Dubielecka
Journal: Blood (2023)
The CD47-Blocking Immune Checkpoint Inhibitor Maplirpacept Does Not Interfere with Blood Transfusion Compatibility Testing
Authors: Mithunah Krishnamoorthy, Natasja N. Viller, Mark Wong, Karen Dodge, Xinli Pang, Robert A. Uger, Gloria H.Y. Lin, Megan M. Kaneda
Journal: Blood (2023)
Tyrosine Kinase Inhibitors with Intensive Chemotherapy in AML with t(9;22)(q34.1;q11.2)/ <i>BCR::ABL1</i>: Time to Reconsider Prognostic Risk? a Study from the Dataml Registry
Authors: Camille Gondran, Pierre-Yves Dumas, Audrey Bidet, Emilie Bérard, Suzanne Tavitian, Thibaut Leguay, Françoise Huguet, Isabelle Luquet, Émilie Klein, Audrey Sarry, Anne-Charlotte De Grande, Eric Delabesse, Édouard Forcade, Cécile Borel, Arnaud Pigneux, Christian Recher, Laetitia Largeaud, Sarah Bertoli
Journal: Blood (2023)
MYC-Alarmin Axis As a Novel Oncogenic Driver in a Subgroup of Triple Negative Myeloproliferative Neoplasms
Authors: Nicole D. Vincelette, Xiaoqing Yu, Andrew T. Kuykendall, Jungwon Moon, Siyuan Su, Chia-Ho Cheng, Rinzine Sammut, Hai Vu Nguyen, Erika Adriana Eksioglu, Onyee Chan, Najla H Al Ali, Parth C. Patel, Dae Hyun Lee, Shima Nakanishi, Renan Ferreira, Qianxing Mo, Suzanne Cory, Harshani Lawrence, Ling Zhang, Daniel Murphy, Rami S. Komrokji, Daesung Lee, Scott H. Kaufmann, John L. Cleveland, Seongseok Yun
Journal: Blood (2023)
Antinuclear and Specific Autoantibodies Predict Autoimmune Disease in Sickle Cell Patients: A Longitudinal Cohort Study
Authors: Frederic Truffinet, Caroline Compain, Maria Elena Manea, Anoosha Habibi, Elena Fois, Etienne Audureau, Sophie Hue, Marc Michel, Pablo Bartolucci
Journal: Blood (2023)
Atgam Efficacy and Safety in Moderate-to-Very Severe Acquired Aplastic Anemia: Outcome of a Large Multicenter Cohort of 634 Children and Adults from the French Authorization for Temporary Use Surveillance Program
Authors: Flore Sicre De Fontbrune, Mony Fahd, Édouard Forcade, Suzanne Tavitian, Cécile Moluçon Chabrot, Fiorenza Barraco, Yosr Hicheri, Delphine Lebon, Sébastien Maury, Anne-Lise Menard, Barbara Możejko-Pastewka, Kevin D Wolter, Bruno Valtier, Thierry Leblanc, Regis Peffault De Latour
Journal: Blood (2023)
<i>ATM</i> Germline Pathogenic Variants Affect Treatment Outcomes in Children with Acute Lymphoblastic Leukemia/Lymphoma and Ataxia Telangiectasia
Authors: Sarah Elitzur, Ruth Shiloh, Jan Loeffen, Agata Pastorczak, Masatoshi Takagi, Simon Bomken, Andre Baruchel, Stephane Ducassou, Nizar Mahlaoui, Marion Strullu, Thomas Lehrnbecher, Kjeld Schmiegelow, Oussama Abla, Liliia Anderzhanova, Nira Arad-Cohen, Itziar Astigarraga, Miriam Ben-Harosh, Francesco Ceppi, Nicole Bodmer, Triantafyllia Brozou, Luciano Dalla-Pozza, Gabriele Escherich, Roula Farah, Amber Gibson, Henrik Hasle, Julieta Hoveyan, Elad Jacoby, Janez Jazbec, Alexandra Kolenova, Jelena Lazic, Luca Lo Nigro, Lane Miller, Vassilios Papadakis, Lucie Pecheux, Marta Pillon, Ifat Sarouk, Jan Stary, Eftichia Stiakaki, Sarah K. Tasian, Thai Hoa Tran, Marek Ussowicz, Jose Jaime Verdu-Amoros, Anna Wakulinska, Joanna Zawitkowska, Dominique Stoppa-Lyonnet, Malcolm Taylor, Yosef Shiloh, Shai Izraeli, Ronit Nirel, Veronique Minard-Colin, Andishe Attarbaschi, Arndt Borkhardt
Journal: Blood (2023)
Dissecting the Single Cell Landscape of Leukemic Mantle Cell Lymphoma
Authors: Tobias Wertheimer, Hosna Baniadam, Stefanie Reisenauer, Marcel Pohly, Lukas Rindlisbacher, Minqi Lin, Stefanie Kreutmair, Susanne Unger, Jarno Kivioja, Andreas Moor, Burkhard Becher, Wolfgang Huber, Thorsten Zenz
Journal: Blood (2023)
TL-895, a Highly Selective, Covalent Inhibitor of Bruton's Tyrosine Kinase (BTK), Sensitizes Myeloproliferative Neoplasm (MPN)-Blast Phase Stem Cells to Navtemadlin By Targeting Intrinsic Dysregulated MDM2/p53 and NF-Κb Pathways and Disrupting the Protective Tumor Microenvironment (TME)
Authors: Xiaoli Wang, Andrew Davis, Xiaoping Su, Muharrem Muftuoglu, Cecile Krejsa, John Mascarenhas, Michael Andreeff, Ronald Hoffman
Journal: Blood (2023)
A Novel High-Throughput Method for Identifying T-Cell Receptor: Minor Histocompatibility Antigen Interactions in Mouse Models of Graft-Vs-Host Disease
Authors: Kevin Quann, Kentin Codispot, Alexander M. Rowe, Wenzhong Wei, Daniel Wikenheiser, Emily McFerran, Mark Shlomchik, Warren Shlomchik
Journal: Blood (2023)
Single-Cell Transcriptomics Reveals Adaptive NK Cell and Antigen-Specific T Cell Responses Shaped by CMV Viremia Post-Hematopoietic Stem Cell Transplant
Authors: Aino-Elina Häkkinen, Jani Huuhtanen, Sofie Lundgren, Riitta Niittyvuopio, Harri Lähdesmäki, Mikko A. I. Keränen, Mikko Myllymäki, Satu Mustjoki
Journal: Blood (2023)
Signaling Pathway Gene Set Enrichment Analysis in Whole Exome Sequencing Data from Discordant Identical Twins Unveils Relevant Pathways As a Clue to Understand Somatic Mutation Acquisition and Clonal Evolution in Myeloproliferative Neoplasms
Authors: Eduard Mas Marin, Sabrina Mir, Eli M Soyfer, Jane H Chen, Jianhong C Heidmann, Simran Bhardwaj, Gajalakshmi Ramanathan, Angela G. Fleischman
Journal: Blood (2023)
Impaired Immunosuppressive Effect of Bone Marrow Mesenchymal Stem Cell-Derived Exosomes on T Cells in Aplastic Anemia
Authors: Shichong Wang, Jiali Huo, Yilin Liu, Lingyun Chen, Xiang Ren, Xingxin Li, Min Wang, Peng Jin, Jinbo Huang, Neng Nie, Jing Zhang, Yingqi Shao, Meili Ge, Yingchang Mi, Yizhou Zheng
Journal: Blood (2023)
Lack of Standardized Coding Limits Accuracy of Electronic Clinical Quality Measure for Pulmonary Embolism Diagnosis
Authors: Lisa Baumann Kreuziger, Megan Keenan, Hayley Dykhoff, Marie Hall, Kyle Campbell, Emily Cahill, Ryan Hanson, Dustin McEvoy, Wei He, Sayon Dutta, Rachel P. Rosovsky, Damon E. Houghton
Journal: Blood (2023)
Obinutuzumab Versus Rituximab in Transplant Eligible Untreated MCL Patients, a Matching Comparison between the Lyma and Lyma-101 Trials
Authors: Clementine Sarkozy, Mary Callanan, Catherine Thieblemont, Lucie Oberic, Barbara Burroni, Krimo Bouabdallah, Gandhi Laurent Damaj, Benoit Tessoulin, Vincent Ribrag, Roch Houot, Franck Morschhauser, Victoria Cacheux, Vincent Delwail, Violaine Safar, Remy Gressin, Morgane Cheminant, Olivier Hermine, Elizabeth A. Macintyre, Steven Le Gouill
Journal: Blood (2023)
MED16 Negatively Regulates Erythropoiesis and Myelopoiesis through Modulation of Chromatin Accessibility
Authors: Sera Xie, Fan Wu, Xinying Zhao, Qiuyu Yue, Shicong Zhu, Ling-Hui Yan, Yuan Zhou, Tong Xing, Qi Hu, Dong Li, Jin-Song Jia, Yuan Kong, Xiao-Jun Huang, Xiaofei Gao, Hsiang-Ying Lee
Journal: Blood (2023)
Defining a Targetable Leukemia Intrinsic Dependency on Noncanonical PI3Kgamma Signaling
Authors: Qingyu Luo, Evangeline G. Raulston, Miguel A. Prado, Xiaowei Wu, Kira Gritsman, Kezhi Yan, Christopher A. G. Booth, Ran Xu, Peter van Galen, John G. Doench, Shai Shimony, Henry W. Long, Donna S. Neuberg, Joao A. Paulo, Andrew A. Lane
Journal: Blood (2023)
Characteristics and Outcomes of Younger Adult Patients (Pts) with Myelodysplastic Syndromes (MDS): A Multicenter Retrospective Study
Authors: Yasmin Abaza, Zhuoer Xie, Madelyn Burkart, Talha Badar, Pinkal Desai, Rory M. Shallis, Anand Ashwin Patel, Adam Cohen-Nowak, Timothy S. Oh, Chelsea Walker, Neela Easwar, Tariq Kewan, Joseph Cannova, Kirsten Bell-Burdett, Najla H Al Ali, David A Sallman, Gail J. Roboz, Hetty E. Carraway, Amer M. Zeidan, Mrinal M. Patnaik, Jessica K. Altman, Rami S. Komrokji
Journal: Blood (2023)
Epcoritamab SC Monotherapy Leads to Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: First Data Disclosure from the Epcore NHL-1 Follicular Lymphoma Dose-Expansion Cohort
Authors: Kim Linton, Wojciech Jurczak, Pieternella Lugtenburg, Emmanuel Gyan, Anna Maria Sureda Balari, Jacob Haaber Christensen, Brian Hess, Hervé Tilly, Raul Cordoba, David Lewis, Craig Okada, Martin Hutchings, Michael Roost Clausen, Umberto Vitolo, Tara Cochrane, Sirpa Leppa, Martine E.D. Chamuleau, Rebekah Conlon, Elena Favaro, Diana Gernhardt, Isil Altintas, Yan Liu, Catherine Thieblemont
Journal: Blood (2023)
Low-Cost Automated Microscopy and Morphology-Based Machine Learning Classification of Sickle Cell Disease and Beta-Thalassemia in Nepal and Canada
Authors: Pranav Shrestha, Hendrik Lohse, Christopher Bhatla, Rodrigo Onell, Nicholas H. C. Au, Ali Amid, Heather McCartney, Alaa Alzaki, Mykola Maydan, Navdeep Sandhu, Hayley Lynne Merkeley, Videsh Kapoor, Rajan Pande, Boris Stoeber
Journal: Blood (2023)
Utility of Bone Marrow Biopsies for Basal Stratification and Response Assessment in a Large Series of Real Life Follicular Lymphoma Patients
Authors: Maria Poza Santaella, Rodrigo Íñiguez, Irene Zamanillo, Tycho S. Baumann, Antonia Rodriguez Izquierdo, Enrique Revilla, Sandra Gomez Rojas, Gloria Perez Segura, Pilar Martinez Sanchez, Carlos Grande, Pilar Sarandeses, Santiago Barrio, Maria Calbacho, Rosa Ayala, Joaquin Martinez-Lopez, Ana Jimenez Ubieto
Journal: Blood (2023)
PBMC-Humanized Mouse Model to Assess Individual Variability in Efficacy and Toxicity of Universal CD19 Chimeric Antigen Receptor T Cell Immunotherapy
Authors: Won Lee, Destanie Rose, Heather Gustafson, Meredith Jackson, Kamila Gwiazda, Joshua Gustafson, Mariliis Ott, Rebecca Gardner, James G Keck, Jiwon Yang
Journal: Blood (2023)
The Impact of Melphalan Conditioning Schedule on Post-Transplant Outcomes in AL Amyloidosis: A Multicenter Study with 1718 Patients
Authors: Eli Muchtar, Vaishali Sanchorawala, Hamza Hassan, Ute Hegenbart, Stefan Schonland, Hans C. Lee, Muzaffar H. Qazilbash, Andrew Kin, Christiane A. Houde, Francis Buadi, Angela Dispenzieri, Eapen K. Jacob, Sally Arai, Michelle Chin MD, Rajshekhar Chakraborty, Suzanne Lentzsch, Hila Magen, Eden Shkury, Caitlin Sarubbi, Heather Landau, Morie A Gertz
Journal: Blood (2023)
Financial Toxicity and Time Toxicity in Multiple Myeloma: Prevalence, Predictors, and Impact on QOL
Authors: Rahul Banerjee, Andrew J. Cowan, Marivel Chavez-Ortega, Paul A Carpenter, Masumi Ueda Oshima, Rachel B. Salit, Phuong T Vo, Catherine J. Lee, Rohtesh S. Mehta, Nicole M. Kuderer, Veena Shankaran, Stephanie J. Lee, Christopher T. Su
Journal: Blood (2023)
The Glass Wall: Gendered Authorship Disparities in in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and Myeloma
Authors: Aroog Khaliq, William Wesson, Emerson Logan, Carine Tabak, Aliya Rashid, Razan Mansour, Muhammad Umair Mushtaq, Joseph P McGuirk, Hamza Hashmi, Mehdi Hamadani, Al-Ola Abdallah, Nausheen Ahmed
Journal: Blood (2023)
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial
Authors: Daniel S.W. Tan, Enriqueta Felip, Gilberto de Castro, Benjamin J. Solomon, Alastair Greystoke, Byoung Chul Cho, Manuel Cobo, Tae Min Kim, Sandip Ganguly, Enric Carcereny, Luis Paz-Ares, Jaafar Bennouna, Marina Chiara Garassino, Michael Schenker, Sang-We Kim, Jan C. Brase, Denise Bury-Maynard, Vanessa Q. Passos, Stéphanie Deudon, Bharani Dharan, Yuanbo Song, Rafael Caparica, Bruce E. Johnson
Journal: Journal of Clinical Oncology (2023)

The addition of checkpoint inhibitors to first-line treatment has prolonged survival of patients with non-small-cell lung cancer (NSCLC), but prognosis remains poor, with new treatment options needed. Canakinumab, a human, monoclonal anti-interleukin (IL)-1β antibody, has potential to enhance the activity of PD-L1 inhibitors and chemotherapy (CT) by inhibiting protumor inflammation.
Neoplastic Monocyte-Derived Fibrocytes Induce Bone Marrow Fibrosis in Patients with Primary Myelofibrosis
Authors: Ivo Veletic, Taghi Manshouri, Christopher D. Pacheco, C. Cameron Yin, Ying Zhang, Ping Li, Evan N. Cohen, Javier A. Gomez, Jared K. Burks, Srdan Verstovsek, Zeev Estrov
Journal: Blood (2023)
Patient Recorded Outcomes from a Randomized, Controlled Phase 2 Trial of E-Selectin Inhibition with Uproleselan Vs Placebo to Reduce GI Toxicity during Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
Authors: Meaghan Ryan, Zachary David Crees, Michael Slade, Mark A. Schroeder, Ravi Vij, Geoffrey L Uy, Keith Stockerl-Goldstein
Journal: Blood (2023)
Outcomes and Prognostic Factors in Patients with Primary Mediastinal B Cell Lymphoma: An Experience from Hematology Cancer Consortium
Authors: Akhil Rajendra, Alok Shetty, Anu Korula, Hasmukh Jain, Mobin Paul, Prasanth Ganesan, Jayachandran Perumal Kalaiyarasi, Santhosh Kumar Devadas, Sushil Selvarajan, Abhilash Menon, Divya K, Parathan Karunakaran, Lingaraj Nayak, Om Prakash, Bhausaheb Bagal, Aby Abraham, Prasanna Samuel, Uday Kulkarni
Journal: Blood (2023)
CAR T Cell Exhaustion but Not <i>Ex Vivo</i> Cytotoxicity Is Predictive of Patient Clinical Response: An Interim Analysis of ACIT001/EXC002, a Phase Ib/II Trial of Decentralized Production of CAR T Cells for Treatment of Relapsed/Refractory Aggressive NHL and ALL
Authors: Charles Yin, Bindu Thapa, Carina Debes-Marun, Zack Breckenridge, Irwindeep Sandhu, Faisal Khan, Michael P. Chu
Journal: Blood (2023)
Trial in Progress: Phase 1 Trial Evaluating the Safety and Tolerability of Odronextamab in Combination with Cemiplimab in Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
Authors: Cecilia Carpio, Manjusha Namuduri, Nazia Iqbal, Dishan Liu, Nickolas Sophos, Min Zhu, Ayesha Sabir, Jurriaan Brouwer-Visser, Aafia Chaudhry, Hesham Mohamed, Alejandro Martín García-Sancho
Journal: Blood (2023)
Investigation of Age-Specific Differences in Survival and Cause of Death Among Diffuse Large B-Cell Lymphoma Patients with and without HIV in the Modern Era of Antiretroviral Therapy: A Population-Based Analysis from 2010 to 2017
Authors: Bryan Valcarcel, Sara J. Schonfeld, Meredith S. Shiels, Jorge J. Castillo, Lindsay M. Morton
Journal: Blood (2023)
Clinical Significance of Measurable Residual Disease (MRD) in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated with Chimeric Antigen Receptor (CAR) T Cells and T-Cell Engagers (TCE)
Authors: Aintzane Zabaleta, Noemi Puig, Maria Teresa Cedena Romero, Jose J Perez, Cristina Moreno, Luis-Esteban Tamariz-Amador, Paula Rodriguez Otero, Veronica Gonzalez-Calle, Lucia Lopez Corral, Beatriz Rey-Búa, Borja Puertas Martínez, Fatima Miras, Jose Sanchez-Pina, Nieves Lopez, Joaquin Martinez-Lopez, Maria Victoria Mateos, Jesus San-Miguel, Bruno Paiva
Journal: Blood (2023)
Mechanism-Based Targeting of Sickle Cell Pathobiology and Pain with Novel Transdermal Curcumin
Authors: Yugal Goel, Mya Angela Arellano, Raghda T Fouda, Daniel Kerr, Sirsendu Jana, Reina Alexis Lomeli, Graham J Velasco, Probal Banerjee, Donovan Alexander Argueta, Mihir Gupta, Richard Prince, Abdu Alayash, Joel Friedman, Kalpna Gupta
Journal: Blood (2023)
Treatment Patterns and Modifications of Tyrosine Kinase Inhibitors (TKI) Therapy in Early Lines in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Real-World Analysis from a Large Commercial Claims Database in the United States (US)
Authors: Vamsi K. Kota, David Wei, Daisy Yang, Hela Romdhani, Dominick Latremouille-Viau, Annie Guérin, Kejal Jadhav
Journal: Blood (2023)
ALDH3A2 Regulates Ferroptosis By Participating in Fatty Acid Synthesis and Finally Lead to Chemotherapy Resistance in Acute Myeloid Leukemia
Authors: Yun Huang, Xuejie Jiang, Ling Jiang, Yujiao Zhang, Fang Liu, Ping Yan, Baoyi Yuan, Quan Wu, Yu Zhao
Journal: Blood (2023)
Rker-050, a Modified Activin Receptor Type Iia Ligand Trap, Promoted Erythropoiesis in a Murine Model of Myelofibrosis
Authors: Blake Moses, Mike Dills, Ashlyn Wheeler, Radina Todorova, Savanna Macaluso, Tyler Damen, Samuel Cadena, Lorena Lerner, Jasbir Seehra, Jenn Lachey
Journal: Blood (2023)
Phase II Trial of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma
Authors: Omar Nadeem, Sophie Magidson, Robert A. Redd, Jacob Laubach, Clifton C. Mo, Elizabeth K. O'Donnell, Adam S. Sperling, Monique A Hartley-Brown, Shonali Midha, Marjorie Marto, Christine Davie, Caroline Ricciardi, Dechen Choden, Ashlee Strutevant, Jillian Alberti, Lorenzo Trippa, Nikhil C Munshi, Kenneth C. Anderson, Paul G. Richardson, Irene M. Ghobrial
Journal: Blood (2023)
Hematopoietic Stem Cell Transplantation for Fanconi Anemia: Outcome and Prognostic Factors for Survival and Subsequent Neoplasms
Authors: Seth J Rotz, Michael Heim, Soyoung Kim, Andrew Gennery, George E. Georges, Kasiani Myers, Larisa Broglie, Hesham Eissa
Journal: Blood (2023)
Lessons Learned from Nanbar Health: Developing a Multi-System Software Suite for Predictive Algorithms and Remote Monitoring for People Living with Sickle Cell Disease
Authors: Arvind Mallikarjunan, Elizabeth Hensley, Abhinav Gundala, Jhana Parikh, Olivia Fernandez, Kumar Utkarsh, Caroline Vuong, Shannon Ford, Nirmish Shah
Journal: Blood (2023)
Cardiovascular Outcomes Among Myeloproliferative Neoplasm Patients with or without Agent Orange Exposure Using a Large Veteran Database
Authors: Andrew Tiu, Zoe McKinnell, Puneet Gill, Martha Antonio, Zoe Shancer, Nandan Srinivasa, Shanshan Liu, Guoqing Diao, Ramesh Subrahmanyam, Craig Kessler, Maneesh Rajiv Jain
Journal: Blood (2023)
An Externally Controlled Trial to Indirectly Compare Tazemetostat Plus Lenalidomide and Rituximab Versus Lenalidomide and Rituximab after at Least One Prior Systemic Therapy in Patients with Refractory and Relapsed Follicular Lymphoma
Authors: Loretta J. Nastoupil, Gilles Salles, John P. Leonard, Frank Morschhauser, Kylee Jordan Veazey, Valerie Perrot, Vitalii Doban, Marion Bonnet, Alexandra Z. Sosinsky, Aaron Crowley, Camryn Lieb, Zhengfan Wang, Bret Zeldow, Joanna Harton, Shu Wang, Tamer Garawin
Journal: Blood (2023)
Leukaemia Exposure Alters the Transcriptional Profile and Function of Macrophages in the Bone Marrow Niche
Authors: Martha M. Zarou, Amy Dawson, Bodhayan Prasad, Joana Bittencourt-Silvestre, Désirée Zerbst, Giovanny Rodriguez Blanco, Mary Scott, Karen Dunn, Vaidehi Krishnan, Mhairi Copland, David Vetrie, Ravi Bhatia, Seth Coffelt, S.Tiong Ong, Helen Wheadon, Sara Zanivan, Kristina Kirschner, G. Vignir Helgason
Journal: Blood (2023)
Pregnancies and Childbirth Following Advanced-Stage Hodgkin Lymphoma Treatment with Brecadd or Beacopp in the Randomized Phase III GHSG HD21 Trial
Authors: Justin Ferdinandus, Gundolf Schneider, Alexander Fosså, Alden Moccia, Richard Greil, Mark S. Hertzberg, Josée M. Zijlstra, Peter Kamper, Daniel L. Molin, Andrea Kerkhoff, Sebastian Scholl, Yon-Dschun Ko, Max S. Topp, Joachim Beck, Vladan Vucinic, Wolfram Jung, Roland Schroers, Andreas Rank, Carla Damaschin, Anne Sophie Jacob, Michael Fuchs, Peter Borchmann, Karolin Behringer
Journal: Blood (2023)
Carfilzomib, Daratumumab, and Dexamethasone (KdD) Vs Carfilzomib and Dexamethasone (Kd) for Relapsed/Refractory Multiple Myeloma (RRMM) in the Phase 3 Candor Study: Subgroup Analysis According to Renal Functioning
Authors: Meletios Athanasios Dimopoulos, Ola Landgren, David S. Siegel, Sebastian Grosicki, Albert Oriol, Rani Najdi, Chuang Li, Khalid Mezzi, Natalie Shu, Hang Quach
Journal: Blood (2023)
Long-Term Efficacy and Safety of Obecabtagene Autoleucel (obe-cel) in Adult Patients (pts) with Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia ([R/R B-ALL]; Pooled Analysis from ALLCAR19 and FELIX Phase Ib Studies) or Other B-cell Malignancies (ALLCAR19 Extension Study)
Authors: Claire Roddie, Eleni Tholouli, Paul Shaughnessy, Elias Jabbour, Aaron C. Logan, Katharine Hodby, Luke Mountjoy, Adrian John Clifton Bloor, David Irvine, David C. Linch, Kim H. Orchard, William Wilson, Bilyana Popova, Juliana Dias, Giulia Agliardi, Victoria Spanswick, Helen Lowe, Marina Mitsikakou, Eftychia Charalambous, Joanna Dawes, Meera Raymond, Yanqing Hu, Wolfram Brugger, Martin A. Pule, Jae H. Park, Karl Peggs
Journal: Blood (2023)
A Phase 1b Study Evaluating the Safety and Efficacy of AK117 (anti-CD47 monoclonal antibody) in Combination with Azacitidine in Patients with Treatment-Naïve Acute Myeloid Leukemia
Authors: Huafeng Wang, Qike Zhang, Qingliang Teng, Zhenyu Li, Hong Liu, Zhongmin Maxwell Wang, Baiyong Li, Yu Xia, Jie Jin
Journal: Blood (2023)
Low Disease Burden Pre-CAR-T Cell Therapy for Children and AYA with B-ALL Is Associated with an Impaired Outcome When Obtained through Intensification of the Bridging Therapy
Authors: Nicolas Lecornec, Marie-Emilie Dourthe, Florence Rabian, Karima Yakouben, Florian Chevillon, Delphine Chaillou, Sophie Caillat-Zucman, Alexis Cuffel, Emmanuelle Lesprit, Anne Arnould, Jérome Naudin, Julie Roupret-Serzec, Nathalie Parquet, Anne Brignier, Valerie Guerin-El Khourouj, Elodie Lainey, Aurélie Caye-Eude, Chloe Arfeuille, Emmanuelle Clappier, Stéphanie Mathis, Marie-Laure Chaix, Elie Azoulay, Jean-Hugues Dalle, Isabelle Madelaine, Jerome Larghero, Nicolas Boissel, André Baruchel
Journal: Blood (2023)
Long-Term Real-World Experience of CPX-351 in Combined French-Italian Cohorts Identified High Rate of Negative Measurable Residual Disease (MRD) and Prolonged Overall Survival
Authors: Thomas Cluzeau, Fabio Guolo, Edmond Chiche, Paola Minetto, Ramy Rahmé, Sarah Bertoli, Livio Pagano, Jean-Baptiste Micol, Michele Gottardi, Pierre Peterlin, Sara Galimberti, Xavier Thomas, Giuliana Rizzuto, Mohamad Mohty, Michela Rondoni, Emmanuel Raffoux, Giambattista Bertani, Alexis Caulier, Michelina Dargenio, Caroline Bonmati, Atto Billio, Caroline Lejeune, Barbara Scappini, Arnaud Pigneux, Patrizia Zappasodi, Christian Recher, Norbert Vey, Francesco Grimaldi, Lionel Ades, Roberto Massimo Lemoli
Journal: Blood (2023)
Assessment of T-Cell Receptor (TCR) Mediated T-Cell Activation in Acute Myeloid Leukemia at Diagnosis Has Implications for Risk Stratification and Response to Immune Checkpoint Inhibitors
Authors: Nancy BJ Arthur, Agata Gruszczynska, Ma Xenia G Illagan, Michael Prinsen, Sharon E Heath, Tasha Burton, Victoria Donaldson, Cara Lunn Shirai, Eric J. Duncavage, Amanda F Cashen, Geoffrey L Uy, David H Spencer, Stephen M Sykes, Timothy J Ley, Francesca Ferraro
Journal: Blood (2023)
Real-World Experience of Individuals with Sickle Cell Disease Treated with Voxelotor: Initial Report from the Multicenter, Prospective Prospect Study
Authors: Biree Andemariam, Henny H. Billett, William B Ershler, Shayla Bergmann, Vishwas S. Sakhalkar, Alicia Chang, Payal Desai, Nirmish Shah, Sharon Pennington, Robin E. Miller, Laura M. Decastro, Michelle Xu, Brooke Hayward, Ching-Ray Yu, Darla K. Liles
Journal: Blood (2023)
Impact of Clinical and Genetic Factors on Myelofibrosis Outcomes after Allogeneic Transplantation
Authors: Mahasweta Gooptu, Haesook T. Kim, Kaina Chen, Ann Mullally, Joseph Antin, Corey Cutler, Amar H Kelkar, John Koreth, Roman M. Shapiro, Robert J. Soiffer, Daniel J. DeAngelo, Jacqueline S. Garcia, Marlise R. Luskin, Richard M Stone, Martha Wadleigh, Eric S. Winer, R. Coleman Lindsley, Vincent Ho
Journal: Blood (2023)
Single-Cell Metabolic Profiling Integrated with Extracellular Vesicle Analysis Reveals Novel Metabolic Vulnerabilities and Prognostic Biomarkers in Acute Myeloid Leukemia
Authors: Dorian Forte, Filippo Maltoni, Samantha Bruno, Paulina Garcia-Gonzalez, Gianluca Cristiano, Chiara Sartor, Simona Soverini, Lucia Catani, Rafael José Argüello, Michele Cavo, Antonio Curti
Journal: Blood (2023)
The <i>SF3B1</i> K666 Hotspot Mutation Confers Unfavourable Disease Risk across Major Myeloid Neoplasm Subgroups
Authors: Jennifer O Sullivan, Amy Wood, Sean Wen, Angela Hamblin, Sonia Fox, Christina Yap, Mary Frances McMullin, Nicholas C. P. Cross, Claire N Harrison, Adam J Mead
Journal: Blood (2023)